SPG(SH:600529) Shang Hai Zheng Quan Bao·2025-10-27 22:43Core Viewpoint - The company, Shandong Pharmaceutical Glass Co., Ltd., has released its third-quarter report for 2025, ensuring the accuracy and completeness of the financial information presented [2][10]. Financial Data - The third-quarter financial statements have not been audited [3]. - The report includes major accounting data and financial indicators, although specific figures are not detailed in the provided text [3]. Non-Recurring Gains and Losses - The company has indicated that it recognizes non-recurring gains and losses, but specific amounts and reasons for classification are not provided [4]. Shareholder Information - The report includes information on the total number of ordinary shareholders and the top ten shareholders, although specific details are not included in the text [5]. Board Meeting Details - The 11th Board of Directors held its third meeting on October 25, 2025, with 9 directors expected and 7 present, while 2 participated via communication [8]. - The meeting was convened by the chairman and followed legal and regulatory procedures [9]. Meeting Resolutions - The board approved the third-quarter report, confirming that the preparation process complies with legal and regulatory requirements, and there are no false statements or omissions [10]. - The voting results were unanimous, with 9 votes in favor and no opposition [11]. Reference Documents - The resolutions from the board's audit committee and the third board meeting are available for review [12].